Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
Reporting to the VP, Commercial Finance and FP&A, the Senior Director, Financial Planning & Analysis (FP&A) will play a critical role in linking planned business activities with actual results. This individual will lead the day-to-day FP&A function, creating financial plans (annual budget and quarterly re-forecasts) and ensuring discipline and transparency in spend through insightful analysis and reporting. This dynamic role spans planning, financial analysis, decision support, accounting and reporting. The successful individual will have a deep understanding of financial analysis methods and approaches, US GAAP, financial processes (and systems) and advanced analytical capabilities that enable them to support the overall organization and Finance leadership. Scholar Rock is a growing organization, requiring a start-up mentality and an ability to work collaboratively to support all areas of the Business and Finance.
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
Join Scholar Rock as the Senior Director of Financial Planning & Analysis (FP&A) in Cambridge, MA, where you’ll play a pivotal role in shaping the financial future of a groundbreaking biopharmaceutical company. At Scholar Rock, we're dedicated to delivering innovative therapies for serious diseases, and your expertise will help bridge the gap between our ambitious business goals and financial realities. As you lead the FP&A team, you’ll foster a strong team culture while managing the annual budget and quarterly re-forecasts to ensure we're on track with our financial commitments. Collaborating with various stakeholders, you’ll create detailed functional financial plans that provide insights into spending, opportunities, and risks. With your extensive knowledge of financial analysis, US GAAP, and advanced modeling skills, you will coach and develop your team while identifying process improvements to enhance efficiency. In this dynamic role, no two days will be the same as you analyze key drivers and variances in our financial landscape, providing vital analysis to aid critical decision-making. Working at Scholar Rock means being part of a passionate team committed to transforming patient lives while supporting each other in a collaborative and inclusive environment. If you’re ready to drive impactful financial strategies in a company that's aiming to redefine treatment paradigms, we’d love for you to be part of our journey.
Relentlessly focused on seeing new possibilities in deep structural insights, validated biologies and antibody technologies to allow us to move with speed and urgency to deliver high-impact medicines to patients with devastating diseases.
10 jobsSubscribe to Rise newsletter